EPA:ORP - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR
Taking everything into account, ORP scores 4 out of 10 in our fundamental rating. ORP was compared to 6 industry peers in the Health Care Providers & Services industry. ORP has a medium profitability rating, but doesn't score so well on its financial health evaluation. ORP is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.74% | ||
ROE | 71.82% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | 26.07% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.3 | ||
Debt/FCF | N/A | ||
Altman-Z | 0.39 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.6 | ||
Quick Ratio | 0.6 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 1.2 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 1.2 | ||
Fwd PE | N/A | ||
P/S | 0.38 | ||
P/FCF | N/A | ||
P/OCF | 5.42 | ||
P/B | 1.05 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.74% | ||
ROE | 71.82% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | 26.07% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.3 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | 8.78% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.6 | ||
Quick Ratio | 0.6 | ||
Altman-Z | 0.39 |